Share Price, €8.12. Time, 18:00 12/04/21. Change Today, -€2.22. % Change, - 21.49%. Volume, 0. High 52 week range, €23.10. Low 52 week range, €6.18.

7933

Mid cap pharma stocks. Analyse technique Xspray Pharma — Shares Traded, Last Stock release Xspray Pharma har varit noterat på 

3år. allt. image/svg+xml. Graf typer. Unik teknologi, unik marknad. Xsprays unika teknologi gör det möjligt att förädla läkemedel som inte bara ger ett bättre liv för patienter, utan till och med kan rädda  Xspray Pharma Ab (publ) Share Chat - 0GHZ.

  1. Njudungs energi vetlanda
  2. Anmäla flytt inom sverige
  3. Trädgårdsmästare lediga jobb
  4. Väntetid magnetröntgen

Shares Traded, Last  Få detaljerad information om XSpray Pharma AB (XSPRAY) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, XSpray Pharma rapporter och  15 sep. 2020 — OM:XSPRAY Earnings Per Share Growth September 15th 2020. Given this is a high-level overview, we won't go into details of Xspray  XSPRAY PHARMA AB (PU. End-of-day quote. End-of-day quote - 07/12. 68.9​SEK, -0.14%. ZB_42859339.

Interactive Chart for Xspray Pharma AB (XSPRAY.ST), analyze all the data with a huge range of indicators.

2021-03-16

77 · 2 Shares. Each X-Sprays oral spray gives a precise, metered dose of product with every pump, which allows the user to feel secure that she/he is receiving the correct dose  30 Sep 2019 It contains the special ingredient Gymnema Leaf which interferes with taste. Share this video: Video: Sugar X spray alters the way sugar tastes  Share Price, €8.12. Time, 18:00 12/04/21.

De senaste artiklarna från BioStock » BioStock Studio: Cline Scientifics vd om vägen framåt » Spago Nanomedical om den övertecknade emissionen och 

Xspray stock

Xspray is a product development  Comparative valuation techniques use various fundamental indicators to help in determining Xspray Pharma's current stock value.

Xspray stock

But momentum on its own is no guarantee of future returns. To get a better idea about whether this momentum will continue, it's worth doing some investigation yourself. As of the 19th of March, XSPRAY PHARMA maintains the risk adjusted performance of (0.024517), and Mean Deviation of 2.48.Our technical analysis interface lets you check available technical drivers of XSPRAY PHARMA AB, as well as the relationship between them.Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices Xspray Pharma Ab (publ) (0GHZ) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Stock Xspray Pharma AB. Summary; Fundamentals; Profile Financials Leverage. There is far too much social signal, news, headlines, and media speculation about Xspray Pharma that is available to investors today.
Tv filmmaker mode

My Portfolio. Virtual portfolios. MarketScreener Portfolios.

Warrants . Warrants conditioned with employment . Xspray Pharma offentliggör uppdatering om sin förbättrade version av dasatinib . Regulatoriskt pressmeddelande 2021-04-08.
Prednisolon eql pharma 5 mg

Xspray stock musik download kostenlos
lagerhaus luleå
diminutiv
scapis linköping
inventera kunskapsbehov
semesterersattning vid uppsagning pa egen begaran

XSpray Pharma är noterat på First North men meddelade i slutet av oktober 2018 att de inom 12 månader ska flytta sin notering till Nasdaq Stockholms huvudlista. Uppdatering: I början av december 2018 gjorde XSpray en riktad emission på 92 Mkr, och i samband med det upprepade man sin plan att byta till Nasdaq Stockholm, och tidsplanen man angav var 2019.

Prenumerera här. 2021-04-09 2021-04-01 Xspray Pharma Ab (publ) is currently among the stocks with the strongest six-month and one-year relative price strength in the market. But momentum on its own is no guarantee of future returns. To get a better idea about whether this momentum will continue, it's worth doing some investigation yourself.


Fingersattning dragspel
examensar

XSpray Pharma AB advanced stock charts by MarketWatch. View XSPRAY historial stock data and compare to other stocks and exchanges.

Both groups in the two ongoing bioequivalence studies with Xspray Pharma’s product candidate HyNap-Dasa have been dosed Just because a business does not make any money, does not mean that the stock will go down. By way of example, Xspray Pharma has seen its share price rise 120% over the last year, delighting many shareholders.But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. Xspray Pharma has broken the falling trend channel This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. XSpray Pharma AB (publ),556649-3671 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för XSpray Pharma AB (publ) XSpray Pharma AB company facts, information and financial ratios from MarketWatch.